| Company Name: |
Cayman Chemical Company
|
| Tel: |
(800) 364-9897 |
| Email: |
cayman@caymanchem.com |
| Products Intro: |
Product Name:3-Methylnordiazepam
CAS:4699-82-5
|
| Company Name: |
Matrix Scientific
|
| Tel: |
803 788-9494 All other calls |
| Email: |
sales@matrixscientific.com |
| Products Intro: |
Product Name:7-Chloro-3-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
CAS:4699-82-5
Purity:>97% Package:$497.00/500mg;$617.00/1g
|
| Company Name: |
Apollo Scientific Ltd.
|
| Tel: |
44 161 406 0505 |
| Email: |
sales@apolloscientific.co.uk |
| Products Intro: |
CAS:4699-82-5
Remarks:OR303072
|
|
| | 3-Methyl-5-phenyl-7-chloro-1H-1,4-benzodiazepine-2(3H)-one Basic information |
| Product Name: | 3-Methyl-5-phenyl-7-chloro-1H-1,4-benzodiazepine-2(3H)-one | | Synonyms: | 3-Methyl-5-phenyl-7-chloro-1,3-dihydro-2H-1,4-benzodiazepine-2-one;3-Methyl-5-phenyl-7-chloro-1H-1,4-benzodiazepine-2(3H)-one;3-Methyl-5-phenyl-7-chloro-2,3-dihydro-1H-1,4-benzodiazepine-2-one;7-Chloro-5-(phenyl)-3-methyl-1H-1,4-benzodiazepin-2(3H)-one;7-Chloro-3-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one;2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-methyl-5-phenyl-;3-Methylnordiazepam | | CAS: | 4699-82-5 | | MF: | C16H13ClN2O | | MW: | 284.74 | | EINECS: | | | Product Categories: | | | Mol File: | 4699-82-5.mol |  |
| | 3-Methyl-5-phenyl-7-chloro-1H-1,4-benzodiazepine-2(3H)-one Chemical Properties |
| Melting point | 217-219 °C(Solv: ethyl acetate (141-78-6)) | | Boiling point | 453.7±45.0 °C(Predicted) | | density | 1.29±0.1 g/cm3(Predicted) | | solubility | DMF: 2 mg/mL; DMSO: 1 mg/mL; Ethanol: Slightly soluble; PBS (pH 7.2): 0.25 mg/mL | | form | A solid | | pka | 11.76±0.70(Predicted) |
| | 3-Methyl-5-phenyl-7-chloro-1H-1,4-benzodiazepine-2(3H)-one Usage And Synthesis |
| Description | 3-Methylnordiazepam is an analytical reference standard categorized as a benzodiazepine.1 3-Methylnordiazepam has anticonvulsant activity in mice. This product is intended for research and forensic applications. | | References | 1. Klopman, G., and Contreras, R. Use of artificial intelligence in structure-activity correlations of anticonvulsant drugs Mol. Pharmacol. 27(1),86-93(1985). |
| | 3-Methyl-5-phenyl-7-chloro-1H-1,4-benzodiazepine-2(3H)-one Preparation Products And Raw materials |
|